Is Elon's Empire Crumbling?
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
Shares Stats
Shares Outstanding | 2,511,030,000 |
Shares Float | 2,509,500,000 |
Shares Short | 28,770,000 |
Insider Holdings | 6% |
Institution Holdings | 80.56% |
About Merck & Co Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and ant
General
Name | Merck & Co Inc |
Ticker | MRK |
Exchange | NYSE |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Currency | USD |
Country | USA |
Fiscal Year End | December |
Full Time Employees | 73,000 |
Highlights
Analyst Target | 100.85 |
Market Cap | 199,099,700,000 |
PE Ratio | 12.22 |
PEG Ratio | 0.75 |
EBITDA | 29,156,999,168 |
Financials
Curr Year EPS Estimate | 8.93 |
Next Quarter EPS Estimate | 2.42 |
Profit Margin | 25.86% |
Operating Margin | 35.05 |
Return on Assets | 0.14 |
Return on Equity | 0.39 |
Revenue | 63.4B |
Earnings Per Share | 6.49 |
Revenue Per Share | 25.23 |
Gross Profit | 49,428,000,768 |
Quarterly Revenue Growth | -0.02 |
Valuation
Trailing PE | 12.04 |
Forward PE | 9.17 |
Price/Sales (Trailing 12 Mt.) | 3.08 |
Price/Book (Most Recent Quarter) | 4.25 |
Dividend
Merck & Co Inc pays out a dividend of $3.14 per share, with a dividend yield of 3.96%.
MRK's next dividend payment will be made to shareholders on October 7, 2025.
They pay out 46.32% of their earnings out as a dividend.
Recent Dividends
Oct 7, 2025 | $0.81 |
Jul 8, 2025 | $0.81 |
Apr 7, 2025 | $0.81 |
Jan 8, 2025 | $0.81 |
Oct 7, 2024 | $0.77 |
Jul 8, 2024 | $0.77 |
Apr 5, 2024 | $0.77 |
Jan 8, 2024 | $0.77 |
Oct 6, 2023 | $0.73 |
Jim Cramer Recommends This 'Really, Really Good' Energy Stock
Cramer also looks at Shutterstock and Getty. One of these companies "doesn't really have the growth" that he'd like to see.
Cathie Wood Doubles Down On Tesla Despite Leadership Exodus, Dumps $22 Million Of Crypto Stocks Amid Bitcoin Buzz
Cathie Wood-led Ark Invest made significant trades on Tuesday, involving major companies like Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Coldplay's jumbotron captures — what exactly? The internet has its theories
LONDON (AP) — It started out as a routine bit of fun at a Coldplay concert: Lead singer Chris Martin asked the cameras to scan the crowd for his “Jumbotron Song,” when he sings a few lines about the people the camera lands on.
Elizabeth Warren Has The Receipts: 'Bribery In Plain Sight' Funding Trump's Library
Several companies have donated to President Donald Trump's future presidential library. Senator Elizabeth Warren calls this potential "bribery in plain sight."
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Donald Trump Files $10 Billion Lawsuit Against WSJ And Rupert Murdoch
Donald Trump has filed a $10 billion defamation lawsuit against The Wall Street Journal and Rupert Murdoch.
Charles Schwab To Launch Bitcoin, Ethereum Trading Services
Charles Schwab (NYSE:SCHW), one of the largest brokerage firms in the United States, has confirmed plans to launch Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO:
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
The Last Time This Warning Flashed, S&P 500 Crashed The Most Since 2008
A rare warning signal has reappeared in the market, with a low bull-bear spread and high investor indecision.
Texas AG claimed three homes as primary residence. Democrats are being probed for similar issue
WASHINGTON (AP) — Texas Attorney General Ken Paxton and his wife, Angela, are longtime owners of a $1.5 million house in a gated community outside Dallas. In 2015, they snapped up a second home in Austin. Then another.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
How Trump could use a building renovation to oust the Fed chair
WASHINGTON (AP) — President says he has finally found a way to achieve his goal of removing Federal Reserve Chair Jerome Powell, accusing him of mismanaging the U.S. central bank’s $2.5 billion renovation project.
Trump-Backed DOJ Motion Seeks Release Of Jeffrey Epstein, Maxwell Grand Jury Transcripts
DOJ moves to unseal grand jury testimony related to Jeffrey Epstein and Ghislaine Maxwell following criticism over handling of documents.
Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
MP Materials, Nvidia, AMD, Alibaba And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Major indices were mixed on Tuesday with the Dow Jones Industrial Average falling nearly 1% to 44,023.29.
Circle CEO: Stablecoins Are Going Mainstream — Fast
Jeremy Allaire, CEO of Circle Internet Group, Inc. (NYSE:CRCL), is offering a compelling vision for the future of digital finance and the role of stablecoins in the global economy.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Tesla Cybertruck Bet Not Paying Off? Ford, GM Outsell EV Giant
Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see declining demand.
Microsoft Q4 Preview: Can The Tech Giant Beat Forecasts For 10th Straight Quarter?
Microsoft has beaten revenue and earnings per share estimates from analysts in the last nine straight quarters. Investors look for another beat and strength in AI and cloud.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Is Costco Stock Topping Out? Key Price Levels To Watch
Costco stock (COST) may have formed a long-term peak. Adhishthana Principles suggest the next move could define the stock's future trajectory.
There are many illegal marijuana farms, but federal agents targeted California's biggest legal one
LOS ANGELES (AP) — There are thousands of illegal marijuana farms around the country.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Japan's governing coalition likely to lose upper house election, exit polls show
TOKYO (AP) — The governing coalition of Prime Minister is likely to lose a majority in the smaller of Japan's two parliamentary houses in a Sunday, according to exit polls, worsening the country's political instability.
Samsung Inks Decade-Long $16.5 Billion Chip Manufacturing Pact With Mystery Tech Giant As It Fights To Regain Ground From TSMC
Samsung has secured a $16.5 billion chipmaking deal with a mystery global client, boosting its foundry ambitions amid stiff AI competition and looming U.S. tariff risks.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.
Elizabeth Warren Sounds Alarm on Tariffs: 'The Impact of Six Months of Donald Trump Will Be Felt for Two Generations'
Sen. Elizabeth Warren has voiced concern over the long-term impact of President Trump's tariffs.
Verizon Beats Expectations, Boosts Outlook — Here's Why Analysts Still See More Room To Grow
Verizon's Q2 results beat expectations, driven by wireless and broadband offerings. Analysts raised price targets, but net additions were lower.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
Bitcoin Flat As $1 Billion Whale Move Sparks Speculation, Ethereum, Dogecoin Spike: Analyst Says BTC's Next Leg Up Will Pump It Above $130,000
Bitcoin consolidated, while other leading coins edged higher alongside stock futures on Sunday.
AI Hallucinations Persist Because Models Can't Access Real-Time, Verifiable Data, Says Nuklai Founder
Amid growing concerns over AI-generated misinformation and hallucinated outputs, Matthijs de Vries, founder of data infrastructure firm Nuklai, argues that better model architecture alone is insufficient. Speaking with Benzinga, de Vries said the deeper issue lies in fragmented and unreliable access to real-time, verifiable data.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Celestica Stock Surges On Q2 Earnings Beat, Company Raises 2025 Outlook On 'Strengthening' Demand
Celestica announces financial results for the second quarter Monday after the bell. Here's a rundown of the supply chain solutions company's report.
Elon Musk's xAI Plans To Raise $12 Billion In Debt To Buy Nvidia Chips And Build One Of The World's Largest AI Superclusters: Report
Elon Musk's xAI is reportedly seeking $12 billion in debt financing to buy Nvidia chips and build a massive AI supercluster, signaling an aggressive push to stay competitive in the global AI arms race.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Can Apple's Slim iPhone And Cheaper Macs Reverse The 2025 Stock Slump?
Apple is expected to rebound in the second half of 2025 with new product launches and strong momentum in its Services division. Analysts reaffirmed a Buy rating with a price forecast of $235.
Federal Reserve likely to stand pat on rates this week, deepening the gulf between Powell and Trump
WASHINGTON (AP) — The Federal Reserve is expected to leave its short-term interest rate unchanged on Wednesday for the fifth straight meeting, a move that will likely underscore between how Chair Jerome Powell and his chief critic, President Donald Trump, see the economy.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
MicroVision Tech On Nvidia Platform — What's Going On?
MicroVision's lidar system is now supported by Nvidia's DRIVE AGX platform, accelerating its adoption in the autonomous vehicle market.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.